Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

INCY

Incyte (INCY)

Incyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INCY
DateTimeSourceHeadlineSymbolCompany
02/07/20237:00AMBusiness WireIncyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
01/30/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/25/202310:38AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
01/24/20234:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/24/20238:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
01/23/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/23/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/18/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/18/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/17/20238:00AMBusiness WireIncyte to Report Fourth Quarter and Year-End 2022 Financial ResultsNASDAQ:INCYIncyte Corporation
01/06/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/06/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/06/20234:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
01/04/20234:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/21/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/15/20228:00AMBusiness WireIncyte to Present at Upcoming Investor ConferencesNASDAQ:INCYIncyte Corporation
12/13/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/12/20226:50AMTipRanksAnalysts Offer Insights on Healthcare Companies: Incyte (INCY) and Aerovate Therapeutics (AVTE)NASDAQ:INCYIncyte Corporation
12/11/20223:00PMBusiness WireIncyte’s Novel Mutant CALR Antibody Unveiled at ASH 2022 Plenary Scientific SessionNASDAQ:INCYIncyte Corporation
12/10/20223:00PMBusiness WireIncyte Announces Data from Two LIMBER Studies Evaluating Combination Treatments in Patients with Myelofibrosis (MF) Presented at ASH 2022NASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY